RADx-UP CDCC SAY YES COVID Test Study
RADx-UP CDCC 同意 COVID 测试研究
基本信息
- 批准号:10366485
- 负责人:
- 金额:$ 765.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-27 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressAdmission activityAffectAttitudeBehaviorBehavioralBioinformaticsBiometryCOVID testCOVID-19 pandemicCenters for Disease Control and Prevention (U.S.)Cessation of lifeClinical ResearchClinical TrialsCommunitiesConsentContact TracingCountyDataData CollectionDiseaseEpidemiologyEvaluationFutureGoalsHealthHealth Knowledge, Attitudes, PracticeHealth behaviorHigh PrevalenceHomeHospitalizationHospitalsHumanIndividualInfectionInfrastructureInterventionKnowledgeLeadLeadershipMeasuresMorbidity - disease rateNorth CarolinaOutcomeParticipantPopulationPopulation ProgramsPreventionPublic HealthQuarantineRADxResearchResearch InstituteSARS-CoV-2 infectionSARS-CoV-2 transmissionScienceSiteSocial InteractionTarget PopulationsTestingTimeUnderserved PopulationUnited States National Institutes of HealthUniversitiesVaccinesViralVirusVisioncohortcommunity engagementcoronavirus diseasecostexperiencehealth care service utilizationhealth equityhome testindexingmarginalized populationnovelnovel strategiesoperationpandemic diseaseprimary outcomeprogramspublic health interventionrapid testresearch studyscreeningsecondary outcomeskillssmartphone Applicationtransmission processuptakewastewater surveillance
项目摘要
Over 4 million people have been infected with the SARS-CoV-2 virus and more than 460,000 have died. Novel
mitigation strategies and community level public health interventions are critical to stop the spread of this virus.
The goal of frequent home testing is to identify SARS-CoV-2 index cases early, trigger isolation and
quarantining precautions, and ultimately decrease community transmission. We will evaluate a public health
intervention combining frequent at-home testing with broad community engagement strategies, to reduce
SARS-CoV-2 virus community transmission and conduct a study in a cohort of the population to understand
the human behavior factors affecting viral testing. This approach will allow us to answer questions regarding
community transmission for the SARS-CoV-2 pandemic as well as additional questions relevant for
implementation of public health interventions in future pandemics. We will partner with the CDC to evaluate
community dissemination of 2 million rapid tests in a public health intervention of rapid, twice weekly at home
testing in up to 3 communities 1) with high prevalence of disease 2) that have reliable publicly available
outcome data and 3) that overlap with current RADx-UP sites to leverage the robust infrastructure of the CDCC
and support community engagement through the testing projects. To evaluate whether frequent rapid at-home
testing strategy decreases community transmission of and morbidity from SARS-CoV-2 over a 5-week period,
our primary outcomes include measures of community transmission (hospital capacity/health care utilization,
composite measure of community transmission, wastewater surveillance), and morbidity (hospitalizations,
covid-like illness). Our secondary outcomes include (community mobility, PCR turn-around time, ICU
admissions, contact tracing episodes, and percent test positivity). In addition, we will conduct a substudy to
assess behavioral determinants of testing (social interaction, health behaviors, healthcare utilization,
prevention knowledge and vaccine attitudes) using a smart phone application with consenting participants in
the public health intervention.
超过400万人感染了SARS-COV-2病毒,超过460,000人死亡。小说
缓解策略和社区层面的公共卫生干预措施对于阻止该病毒的传播至关重要。
频繁进行家庭测试的目的是尽早确定SARS-COV-2指数案例,触发隔离和
隔离预防措施,并最终减少社区传播。我们将评估公共卫生
干预将频繁的家庭测试与广泛的社区参与策略相结合,以减少
SARS-COV-2病毒社区传播并在一群人群中进行研究以了解
影响病毒测试的人类行为因素。这种方法将使我们回答有关
SARS-COV-2大流行的社区传播以及与
在未来大流行中实施公共卫生干预措施。我们将与CDC合作评估
社区传播200万快速测试,在快速的公共卫生干预措施中,每周两次
在多达3个社区中进行测试1)疾病患病率很高2)公开可靠的
结果数据和3)与当前RADX站点重叠以利用CDCC的稳健基础架构
并通过测试项目支持社区参与。评估是否频繁地在家中
测试策略可在5周的时间内降低SARS-COV-2的社区传播和发病率,
我们的主要结果包括社区传播的措施(医院能力/医疗保健利用,
社区传播,废水监测的综合度量)和发病率(住院,
类似疾病)。我们的次要结果包括(社区移动性,PCR转身时间,ICU
入学,接触示意发作和测试阳性百分比)。此外,我们将进行
评估测试的行为决定因素(社交互动,健康行为,医疗保健利用,
预防知识和疫苗态度)使用同意参与者使用智能手机应用程序
公共卫生干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Cohen-Wolkowiez其他文献
Michael Cohen-Wolkowiez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Cohen-Wolkowiez', 18)}}的其他基金
RADx-UP SAY YES COVID Test Study (S4)
RADx-UP 说“是”新冠病毒测试研究 (S4)
- 批准号:
10472985 - 财政年份:2020
- 资助金额:
$ 765.38万 - 项目类别:
Mentoring in Clinical Pharmacology and Early Phase Trials
临床药理学和早期试验的指导
- 批准号:
10394817 - 财政年份:2019
- 资助金额:
$ 765.38万 - 项目类别:
Mentoring in Clinical Pharmacology and Early Phase Trials
临床药理学和早期试验的指导
- 批准号:
10620632 - 财政年份:2019
- 资助金额:
$ 765.38万 - 项目类别:
Physiologically-Based Pharmacokinetic Models for Optimal Drug Dosing in Children
基于生理学的儿童最佳药物剂量的药代动力学模型
- 批准号:
8661919 - 财政年份:2014
- 资助金额:
$ 765.38万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Identification of Risk Factors for predicting outcomes of COVID-19-Related Multisystem Inflammatory Syndrome in Children (MISC) using Real World Clinical Data
使用真实世界临床数据识别预测 COVID-19 相关儿童多系统炎症综合征 (MISC) 结果的风险因素
- 批准号:
10527735 - 财政年份:2022
- 资助金额:
$ 765.38万 - 项目类别:
Identification of Risk Factors for predicting outcomes of COVID-19-Related Multisystem Inflammatory Syndrome in Children (MISC) using Real World Clinical Data
使用真实世界临床数据识别预测 COVID-19 相关儿童多系统炎症综合征 (MISC) 结果的风险因素
- 批准号:
10679093 - 财政年份:2022
- 资助金额:
$ 765.38万 - 项目类别:
Investigating SARS-CoV-2 transmission dynamics in jails to address the COVID-19 public health emergency
调查监狱中 SARS-CoV-2 的传播动态,以应对 COVID-19 公共卫生紧急情况
- 批准号:
10688288 - 财政年份:2022
- 资助金额:
$ 765.38万 - 项目类别:
Role of PD1 blockade and IL-10 during infection in aging
PD1 阻断和 IL-10 在衰老感染过程中的作用
- 批准号:
10704181 - 财政年份:2022
- 资助金额:
$ 765.38万 - 项目类别: